Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MCF 10A | Ulixertinib | 0.1 | 0.7855 | -0.00259 |
| MCF 10A | Ulixertinib | 0.1 | 0.7522 | 0.00349 |
| MCF 10A | Ulixertinib | 0.1 | 0.7521 | 0.00192 |
| MCF 10A | Ulixertinib | 0.316227766 | 0.5828 | 0.00007 |
| MCF 10A | Ulixertinib | 0.316227766 | 0.5553 | 0.00962 |
| MCF 10A | Ulixertinib | 0.316227766 | 0.5852 | 0.00924 |
| MCF 10A | Ulixertinib | 1.0 | 0.5848 | 0.00005 |
| MCF 10A | Ulixertinib | 1.0 | 0.5600 | 0.00901 |
| MCF 10A | Ulixertinib | 1.0 | 0.5958 | 0.00578 |
| MCF 10A | Ulixertinib | 3.16227766 | 0.3849 | 0.00461 |
| MCF 10A | Ulixertinib | 3.16227766 | 0.4012 | 0.01166 |
| MCF 10A | Ulixertinib | 3.16227766 | 0.4558 | 0.00971 |
| MCF 10A | Ulixertinib | 10.0 | 0.1985 | 0.00683 |
| MCF 10A | Ulixertinib | 10.0 | 0.1637 | 0.04222 |
| MCF 10A | Ulixertinib | 10.0 | 0.1886 | 0.03771 |
| MCF 10A | Alvocidib | 0.0001 | 1.0102 | -0.00142 |
| MCF 10A | Alvocidib | 0.0001 | 1.0355 | 0.00070 |
| MCF 10A | Alvocidib | 0.0001 | 0.9939 | 0.00158 |
| MCF 10A | Alvocidib | 0.000316228 | 1.0115 | -0.00239 |
| MCF 10A | Alvocidib | 0.000316228 | 1.0103 | 0.00226 |
| MCF 10A | Alvocidib | 0.000316228 | 1.0035 | 0.00083 |
| MCF 10A | Alvocidib | 0.001 | 1.0347 | -0.00183 |
| MCF 10A | Alvocidib | 0.001 | 1.0303 | 0.00025 |
| MCF 10A | Alvocidib | 0.001 | 1.0086 | 0.00213 |
| MCF 10A | Alvocidib | 0.003162278 | 1.0325 | -0.00228 |